🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The investigators conducted a phase II, prospective, two-arm clinical study...
Status
Unknown
Location
Fujian Medical University Union Hospital
Start Date
2023-05-25
Trial ID
NCT05821452
Treatments Being Tested
This is a prospective, single-center, single-arm study evaluating the combi...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute & Hospital
Start Date
2025-11-01
Trial ID
NCT07281157
Treatments Being Tested
This is a randomized, open-label, prospective, multicenter phase III superi...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center,
Start Date
2026-08-11
Trial ID
NCT07678229
This is an open-label randomized phase II study. Patients are randomized so...
Status
Withdrawn
Location
University of California
Start Date
2015-06
Trial ID
NCT01530984
Treatments Being Tested
To explore the efficiency and safety of Tislelizumab combinated with carbop...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-04-20
Trial ID
NCT06366945
It is a non-randomized pilot study.The allocation will be determined by pat...
Status
Completed
Location
Capital Medical Unvierstiy Cancer Center/ Beijing Shijitan Hospital
Start Date
2018-03-01
Trial ID
NCT03757858
Treatments Being Tested
This trial will study the safety and tolerability and disease survival rate...
Status
Recruiting
Location
UPMC Hillman Cancer
Start Date
2026-04-06
Trial ID
NCT07423078
Treatments Being Tested
To explore the efficacy of incorporating neoadjuvant immunotherapy into neo...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute & Hospital
Start Date
2023-11-01
Trial ID
NCT06093438
Treatments Being Tested
The goal of this clinical trial is to evaluate if adding chemotherapy and i...
Status
Not Yet Recruiting
Location
Fudan Universtiy Shanghai Cancer Center
Start Date
2026-09-01
Trial ID
NCT07776340
In this study, the investigators designed a randomized, open-label, phase I...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2026-02-10
Trial ID
NCT07392320
Treatments Being Tested